Monitoring in clinical biochemistry

Jenny Doust*, Paul Glasziou

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

3 Citations (Scopus)

Abstract

Monitoring tests form an increasing proportion of the workload in clinical biochemistry and biochemists can help by providing clinicians with information about the variability and precision of tests, the time frame for pharmacodynamic stabilisation after a treatment change, and the frequency of testing. This paper outlines the phases of monitoring, and how to decide if monitoring is beneficial, which test to use for monitoring, when a change in the test result indicates a need for the change in treatment and the length of testing intervals. We conclude with some recommendations for biochemists for future areas of research and advice that can be given to clinicians.
Original languageEnglish
Pages (from-to)85-92
Number of pages8
JournalClinical Biochemist Reviews
Volume34
Issue number2
Publication statusPublished - Aug 2013

    Fingerprint

Cite this